Bevacizumab in colorectal cancer.
Guru
G
Sonpavde
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D018592:Cross-Over Studies; D018450:Disease Progression; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic / Q000941:ethics*; D012107:Research Design
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab